Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Pimentel

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Microbiology|July 9, 2024
Editorial: Cross-boundary significance of methanogens - the methane moment and beyondZhe Lyu, Amelia-Elena Rotaru, Mark Pimentel, et al.
Digestive Diseases and Sciences|April 17, 2013
The effect of rifaximin on gut flora and Staphylococcus resistanceMi-Sung Kim, Walter Morales, Andres Ardila Hani, et al.
Digestive Diseases and Sciences|August 25, 2012
Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptyingAndres Ardila-Hani, Mane Arabyan, Alan Waxman, et al.
Photodiagnosis and Photodynamic Therapy|April 27, 2024
Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independentGabriela Leite, Sepideh Mehravar, Mark Pimentel, et al.
Communications Medicine|April 8, 2026
Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndromeSepideh Mehravar, Yee Hui Yeo, Mark Pimentel, et al.
The American Journal of Gastroenterology|December 14, 2020
ACG Clinical Guideline: Management of Irritable Bowel SyndromeBrian E Lacy, Mark Pimentel, Darren M Brenner, et al.
Gut Microbes|May 1, 2018
Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndromeAnthony A Fodor, Mark Pimentel, William D Chey, et al.
Digestive Diseases and Sciences|January 12, 2011
Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBSMark Pimentel, Walter Morales, Sam-Ryong Jee, et al.
Neurogastroenterology and Motility|May 22, 2020
Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndromeWalter Morales, Konstantinos Triantafyllou, Gonzalo Parodi, et al.
Menopause (New York, N.Y.)|February 25, 2022
Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular riskGabriela Leite, Gillian M Barlow, Gonzalo Parodi, et al.
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Microbiology|July 9, 2024
Editorial: Cross-boundary significance of methanogens - the methane moment and beyondZhe Lyu, Amelia-Elena Rotaru, Mark Pimentel, et al.
Digestive Diseases and Sciences|April 17, 2013
The effect of rifaximin on gut flora and Staphylococcus resistanceMi-Sung Kim, Walter Morales, Andres Ardila Hani, et al.
Digestive Diseases and Sciences|August 25, 2012
Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptyingAndres Ardila-Hani, Mane Arabyan, Alan Waxman, et al.
Photodiagnosis and Photodynamic Therapy|April 27, 2024
Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independentGabriela Leite, Sepideh Mehravar, Mark Pimentel, et al.
Communications Medicine|April 8, 2026
Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndromeSepideh Mehravar, Yee Hui Yeo, Mark Pimentel, et al.
The American Journal of Gastroenterology|December 14, 2020
ACG Clinical Guideline: Management of Irritable Bowel SyndromeBrian E Lacy, Mark Pimentel, Darren M Brenner, et al.
Gut Microbes|May 1, 2018
Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndromeAnthony A Fodor, Mark Pimentel, William D Chey, et al.
Digestive Diseases and Sciences|January 12, 2011
Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBSMark Pimentel, Walter Morales, Sam-Ryong Jee, et al.
Neurogastroenterology and Motility|May 22, 2020
Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndromeWalter Morales, Konstantinos Triantafyllou, Gonzalo Parodi, et al.
Menopause (New York, N.Y.)|February 25, 2022
Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular riskGabriela Leite, Gillian M Barlow, Gonzalo Parodi, et al.
Pageof 20